In the realm of healthcare, a paradigm shift is needed to recognize prevention as a cornerstone of economic prosperity, rather than a mere cost. The recent Wild Health Preventative Care Conference in Canberra sparked a crucial conversation: why do we persist in viewing prevention as a health expense rather than a strategic investment in our nation's future? This question is not merely academic; it carries profound implications for Australia's economic health and overall well-being. As Dr. Ramya Raman, a specialist GP and practice owner, astutely observes, prevention is not just about avoiding illness; it's about fostering a more productive and resilient society.
The numbers are striking. Australia's healthcare expenditure in 2023-24 amounted to a staggering $270.5 billion, yet only a fraction, $14.6 billion, was directed towards preventive care, primarily through general practice. This prevention gap is not just a financial oversight; it's a missed opportunity to address the root causes of chronic diseases and reduce the burden on our healthcare system. The Australian Institute of Health and Welfare estimates that $38 billion in health spending in 2023-24 was attributed to avoidable risk factors, with overweight and obesity alone costing $7 billion. These figures are not mere statistics; they represent lives, families, and communities affected by preventable illnesses.
The Australian Burden of Disease Study 2024 reveals a startling fact: 36% of Australia's disease burden could be averted or reduced by tackling modifiable risk factors. This includes the pervasive issues of overweight and obesity, tobacco use, poor diet, high blood pressure, and high blood plasma glucose. Behind these numbers are real people, families, and communities struggling with preventable health issues. For instance, a parent whose diabetes could have been detected earlier, a worker whose heart disease risk could have been managed, or an older person whose fall or infection could have been prevented with timely community care.
The ACE-Prevention study and the ACE-Obesity Policy study provide compelling evidence that many preventive interventions are not only cost-effective but also cost-saving. Yet, prevention continues to lose out to short-term budget cycles. Governments often prioritize visible issues like hospital ramping, waiting lists, and crisis management, while prevention, being quieter and less immediately visible, is overlooked. This is where the real productivity lies, in the prevention of avoidable illnesses and the subsequent reduction in healthcare costs.
To address this, we need a National Prevention Investment Framework with real authority. This framework should be led by an independent, cross-sector advisory body capable of evaluating preventive health investments, modeling their economic and health returns, and recommending strategic investments. Prevention funding must be pooled across Commonwealth, state, and territory governments to ensure a cohesive and comprehensive approach. Long-term funding is essential to prevent the short-term enthusiasm for prevention from fading.
Moreover, prevention must be equitable, prioritizing Aboriginal and Torres Strait Islander peoples, rural and remote communities, people living in poverty, people with disabilities, and communities with a higher burden of preventable diseases. A productivity lens, while useful, should not narrow the focus to workforce participation alone. Instead, it should be a catalyst for a broader conversation on health as economic infrastructure.
In conclusion, the time has come to treat prevention as the investment it is, not just a cost. By doing so, we can build a healthier, more productive, and equitable society. The challenge is not just in recognizing the need for change but in translating that recognition into action. As Dr. Raman aptly puts it, the question is whether we are prepared to fund prevention as seriously as we fund rescue. It's a call to action that demands our attention and commitment to a brighter, healthier future for all.
